Affiliations 

  • 1 Vijayan Valayatham, MD (USM), MRCOG(London). Maternal Fetal Medicine Specialist, Sabah Women & Children Hospital, Kota Kinabalu, Malaysia. vj1vela@gmail.com
Med J Malaysia, 2012 Aug;67(4):399-401.
PMID: 23082449 MyJurnal

Abstract

AIM: We audited indications and outcomes of antiphospholipid syndrome (APS) screening in the pregnant population at our centre.
METHOD: Prospective and observational. All APS test results returned were audited for validity of indication and subsequent outcome.
RESULT: 24 of a total of 146 (16%) of requests for the antiphospholipid antibodies and lupus anticoagulant were not indicated. Two positive results returned for a total of 116 "indicated" requests (1.7%).
CONCLUSION: There needs to be increased awareness among obstetricians on the indications for screening for antiphospholipid syndrome (APS). The prevalence of antiphospholipid syndrome with obstetric manefestations in the study population is lower than rates published in the literature.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.